Iridex Affirms 2026 Guidance as Glaucoma Product Sales Offset Retina Weakness
Iridex Corporation reaffirmed its 2026 financial outlook after reporting a nearly flat first quarter, with growth in its glaucoma product family and service rev
Iridex Corporation reaffirmed its 2026 financial outlook after reporting a nearly flat first quarter, with growth in its glaucoma product family and service rev
Siemens AG delivered a second-quarter earnings report that underscored both the resilience and the tension in its investment case: customers are placing more or
Visa delivered stronger-than-expected fiscal second-quarter results on Tuesday, as the world’s largest payments network benefited from steady card spending, res